STAT3 and neoplasm: The inhibitor significantly reduced tumor radioactivity accumulation and the tumor-to-blood ratio in the xenografted mice after [18F]FBNAF administration, suggesting the specific binding of [18F]FBNAF to STAT3 in tumor tissues.